Delpha Drugs And Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 38 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.75 Cr
as on 23-12-2024
- Revenue -98.82%
(FY 2022)
- Profit -111.21%
(FY 2022)
- Ebitda -104.04%
(FY 2022)
- Net Worth -11.70%
(FY 2022)
- Total Assets -67.38%
(FY 2022)
About Delpha Drugs And Pharmaceuticals (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.75 Cr.
Vipin Parikh and Hema Parikh serve as directors at the Company.
- CIN/LLPIN
U24230MH1986PTC040681
- Company No.
040681
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Delpha Drugs And Pharmaceuticals (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipin Parikh  | Director | 28-Aug-1986 | Current |
| Hema Parikh | Director | 10-Jan-2007 | Current |
Financial Performance of Delpha Drugs And Pharmaceuticals (India).
Delpha Drugs And Pharmaceuticals (India) Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.82% decrease. The company also saw a substantial fall in profitability, with a 111.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Delpha Drugs And Pharmaceuticals (India)?
In 2020, Delpha Drugs And Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 09 Oct 2017 | ₹1.75 Cr | Open |
How Many Employees Work at Delpha Drugs And Pharmaceuticals (India)?
Unlock and access historical data on people associated with Delpha Drugs And Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Delpha Drugs And Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delpha Drugs And Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
